Paradigm Biopharmaceutica Pink Sheet Forecast - Price Action Indicator
| PBIGF Stock | USD 0.22 0.02 8.33% |
Paradigm Pink Sheet outlook is based on your current time horizon. We recommend always using this module together with an analysis of Paradigm Biopharmaceutica's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 29th of January 2026, the relative strength index (RSI) of Paradigm Biopharmaceutica's share price is approaching 44 indicating that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Paradigm Biopharmaceutica, making its price go up or down. Momentum 44
Sell Extended
Oversold | Overbought |
Using Paradigm Biopharmaceutica hype-based prediction, you can estimate the value of Paradigm Biopharmaceuticals Limited from the perspective of Paradigm Biopharmaceutica response to recently generated media hype and the effects of current headlines on its competitors.
Paradigm Biopharmaceutica after-hype prediction price | USD 0.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Paradigm |
Paradigm Biopharmaceutica Additional Predictive Modules
Most predictive techniques to examine Paradigm price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Paradigm using various technical indicators. When you analyze Paradigm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Paradigm Biopharmaceutica Volatility | Backtest Paradigm Biopharmaceutica | Information Ratio |
Paradigm Biopharmaceutica Trading Date Momentum
| On January 29 2026 Paradigm Biopharmaceuticals Limited was traded for 0.22 at the closing time. The highest daily price throughout the period was 0.22 and the lowest price was 0.22 . There was no trading activity during the period 0.0. Lack of trading volume on 01/29/2026 did not cause price change. The trading delta at closing time to current closing price is 0.00% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Paradigm Biopharmaceutica to competition |
Other Forecasting Options for Paradigm Biopharmaceutica
For every potential investor in Paradigm, whether a beginner or expert, Paradigm Biopharmaceutica's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Paradigm Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Paradigm. Basic forecasting techniques help filter out the noise by identifying Paradigm Biopharmaceutica's price trends.Paradigm Biopharmaceutica Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Paradigm Biopharmaceutica pink sheet to make a market-neutral strategy. Peer analysis of Paradigm Biopharmaceutica could also be used in its relative valuation, which is a method of valuing Paradigm Biopharmaceutica by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Paradigm Biopharmaceutica Market Strength Events
Market strength indicators help investors to evaluate how Paradigm Biopharmaceutica pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Paradigm Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Paradigm Biopharmaceutica pink sheet market strength indicators, traders can identify Paradigm Biopharmaceuticals Limited entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.92 | |||
| Day Median Price | 0.22 | |||
| Day Typical Price | 0.22 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) | |||
| Relative Strength Index | 44.38 |
Paradigm Biopharmaceutica Risk Indicators
The analysis of Paradigm Biopharmaceutica's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Paradigm Biopharmaceutica's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting paradigm pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.94 | |||
| Standard Deviation | 7.23 | |||
| Variance | 52.26 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Paradigm Biopharmaceutica
The number of cover stories for Paradigm Biopharmaceutica depends on current market conditions and Paradigm Biopharmaceutica's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Paradigm Biopharmaceutica is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Paradigm Biopharmaceutica's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Paradigm Pink Sheet
Paradigm Biopharmaceutica financial ratios help investors to determine whether Paradigm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Paradigm with respect to the benefits of owning Paradigm Biopharmaceutica security.